Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie L Saundh

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Crystals|November 8, 2021
Engineering Crystal Packing in RNA Structures I: Past and Future Strategies for Engineering RNA Packing in CrystalsNarsimha Pujari, Stephanie L Saundh, Francis A Acquah, et al.
Human Vaccines & Immunotherapeutics|June 10, 2026
Safety and immunogenicity of a booster dose of COVAC-2, a Sepivac SWE™ adjuvanted SARS-CoV-2 recombinant protein vaccine in previously vaccinated healthy adults; a randomized controlled multicentre trialGlenn Hamonic, Supriya Arora, Ravendra Garg, et al.
ACS Chemical Neuroscience|November 30, 2020
Identification and Mechanistic Characterization of a Peptide Inhibitor of Glycogen Synthase Kinase (GSK3β) Derived from the Disrupted in Schizophrenia 1 (DISC1) ProteinStephanie L Saundh, Debasis Patnaik, Steve Gagné, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 29, 2025
Ebola virus matrix protein VP40 triggers inflammatory responses linked to the ebolavirus virulenceSatoko Yamaoka, Zeineb M'Hamdi, Lin Wang, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Crystals|November 8, 2021
Engineering Crystal Packing in RNA Structures I: Past and Future Strategies for Engineering RNA Packing in CrystalsNarsimha Pujari, Stephanie L Saundh, Francis A Acquah, et al.
Human Vaccines & Immunotherapeutics|June 10, 2026
Safety and immunogenicity of a booster dose of COVAC-2, a Sepivac SWE™ adjuvanted SARS-CoV-2 recombinant protein vaccine in previously vaccinated healthy adults; a randomized controlled multicentre trialGlenn Hamonic, Supriya Arora, Ravendra Garg, et al.
ACS Chemical Neuroscience|November 30, 2020
Identification and Mechanistic Characterization of a Peptide Inhibitor of Glycogen Synthase Kinase (GSK3β) Derived from the Disrupted in Schizophrenia 1 (DISC1) ProteinStephanie L Saundh, Debasis Patnaik, Steve Gagné, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 29, 2025
Ebola virus matrix protein VP40 triggers inflammatory responses linked to the ebolavirus virulenceSatoko Yamaoka, Zeineb M'Hamdi, Lin Wang, et al.
Pageof 1